# Gilead Sciences, Inc.: Form 4, filed Jan 31, 2024

- Company: [Gilead Sciences, Inc.](/companies/gild.md) (CIK 882095)
- Form: 4
- Filed: 2024-01-31
- Accepted by EDGAR: Jan 31, 2024, 17:00 ET
- Period: 2024-01-29
- Accession: 0001104659-24-008868
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/882095/000110465924008868/xslF345X05/tm244648-1_4seq1.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882095/000110465924008868/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882095/000110465924008868/xslF345X05/tm244648-1_4seq1.xml

Filed Jan 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-008868. Last ingested by Listed: Nov 13, 2026, 16:08 ET. No prices; not investment advice.